5299 篇
13868 篇
408771 篇
16079 篇
9269 篇
3868 篇
6464 篇
1238 篇
72401 篇
37107 篇
12060 篇
1619 篇
2821 篇
3387 篇
640 篇
1229 篇
1965 篇
4866 篇
3821 篇
5293 篇
全球脑膜炎球菌疫苗市场报告(2014-2018年)
Global Meningococcal Vaccines Market 2014-2018
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Market Segmentation by Composition
07.1 Mono Vaccines
07.1.1 Polysaccharide Vaccines
07.1.2 Conjugate Vaccines
07.2 Combination Vaccines
08. Geographical Segmentation
09. Key Leading Countries
09.1 US
09.2 Brazil
10. Buying Criteria
11. Market Growth Drivers
12. Drivers and their Impact
13. Market Challenges
14. Impact of Drivers and Challenges
15. Market Trends
16. Trends and their Impact
17. Vendor Landscape
17.1 Competitive Scenario
17.1.1 Key News
17.2 Market Share Analysis 2013
17.2.1 GlaxoSmithKline
17.2.2 Novartis
17.2.3 Sanofi Pasteu
17.3 Other Prominent and Future Vendors
18. Late-stage Pipeline Candidates
18.1 Key Information of Late-stage Pipeline
Candidates
18.1.1 Bexsero
18.1.2 rLP2086
18.1.3 MCV-ACYW135 Vaccine
19. Key Vendor Analysis
19.1 GlaxoSmithKline
19.1.1 Key Facts
19.1.2 Business Overview
19.1.3 Business Segmentation
19.1.4 Business Segmentation by Revenue 2012 and 2013
19.1.5 Geographical Segmentation by Revenue
19.1.6 Pipeline Products
19.1.7 Business Strategy
19.1.8 Key Information
19.1.9 SWOT Analysis
19.2 Sanofi Pasteur
19.2.1 Key Facts
19.2.2 Business Overview
19.2.3 Business Strategy
19.2.4 Recent Developments
19.2.5 SWOT Analysis
19.3 Novartis
19.3.1 Key Facts
19.3.2 Business Overview
19.3.3 Business Segmentation by Revenue 2013
19.3.4 Business Segmentation by Revenue 2012 and 2013
19.3.5 Geographical Segmentation by Revenue
19.3.6 Business Strategy
19.3.7 Key Developments
19.3.8 SWOT Analysis